Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hordinsky

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Drugs in Dermatology : JDD|August 7, 2025
Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance CompaniesSonja Kobayashi, Samantha Rojas, Olivia Ueltschi, et al.
Journal of the American Academy of Dermatology|April 11, 2025
Summation and recommendations for the safe and effective use of topical and oral minoxidilElise A Olsen, Rodney Sinclair, Maria Hordinsky, et al.
Skin Appendage Disorders|April 2, 2021
Thirty Years (and More) of Hair Research SocietiesGill Westgate, Wilma F Bergfeld, Victoria Ceh, et al.
Journal of the American Academy of Dermatology|September 1, 2007
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in menElise A Olsen, David Whiting, Wilma Bergfeld, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Regenerative Medicine for Hair Health: From Principles to Practice (Part II)Saranya P Wyles, Sydney L Proffer, Larissa Pastore, et al.
Journal of the American Academy of Dermatology|April 19, 2021
Reply to: Response to "Inconsistent platelet-rich plasma product from Food and Drug Administration cleared devices: A retrospective review of clinic data"Ronda S Farah, Noora Hussain, Javed A Shaik, et al.
American Journal of Clinical Dermatology|January 30, 2014
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind studyJoaquin J Jimenez, Tongyu C Wikramanayake, Wilma Bergfeld, et al.
Journal of the American Academy of Dermatology|January 12, 2021
Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic dataMeyeneobong Inyang, Javed A Shaik, Noora Hussain, et al.
Journal of the American Academy of Dermatology|November 18, 2006
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasterideElise A Olsen, Maria Hordinsky, David Whiting, et al.
Journal of the American Academy of Dermatology|April 21, 2019
Thirty years (and more) of hair research societiesGillian E Westgate, Wilma F Bergfeld, Victoria Ceh, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Drugs in Dermatology : JDD|August 7, 2025
Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance CompaniesSonja Kobayashi, Samantha Rojas, Olivia Ueltschi, et al.
Journal of the American Academy of Dermatology|April 11, 2025
Summation and recommendations for the safe and effective use of topical and oral minoxidilElise A Olsen, Rodney Sinclair, Maria Hordinsky, et al.
Skin Appendage Disorders|April 2, 2021
Thirty Years (and More) of Hair Research SocietiesGill Westgate, Wilma F Bergfeld, Victoria Ceh, et al.
Journal of the American Academy of Dermatology|September 1, 2007
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in menElise A Olsen, David Whiting, Wilma Bergfeld, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Regenerative Medicine for Hair Health: From Principles to Practice (Part II)Saranya P Wyles, Sydney L Proffer, Larissa Pastore, et al.
Journal of the American Academy of Dermatology|April 19, 2021
Reply to: Response to "Inconsistent platelet-rich plasma product from Food and Drug Administration cleared devices: A retrospective review of clinic data"Ronda S Farah, Noora Hussain, Javed A Shaik, et al.
American Journal of Clinical Dermatology|January 30, 2014
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind studyJoaquin J Jimenez, Tongyu C Wikramanayake, Wilma Bergfeld, et al.
Journal of the American Academy of Dermatology|January 12, 2021
Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic dataMeyeneobong Inyang, Javed A Shaik, Noora Hussain, et al.
Journal of the American Academy of Dermatology|November 18, 2006
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasterideElise A Olsen, Maria Hordinsky, David Whiting, et al.
Journal of the American Academy of Dermatology|April 21, 2019
Thirty years (and more) of hair research societiesGillian E Westgate, Wilma F Bergfeld, Victoria Ceh, et al.
Pageof 8